SIERRA MORGAN: Open Payments
NPI 1235557752 · NORTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 83 payments from 18 companies in 2025. Trend: 2023 $1,082 · 2024 $1,589 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $226 |
| ABBVIE INC. | 19 | $193 |
| AstraZeneca Pharmaceuticals LP | 7 | $165 |
| Amgen Inc. | 13 | $135 |
| Abbott Laboratories | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| PFIZER INC. | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
Products named: VRAYLAR, Wegovy, FREESTYLE LIBRE 3, OTEZLA, FARXIGA, AIRSUPRA, Rybelsus, Kerendia.
Industry payments across VA — which companies pay providers there.
